Aurora (1)

New York (1)

STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder (1)

Active, not recruiting (1)

early phase 1 (1)

Weill Medical College of Cornell University (1)

Children's Hospital Colorado (1)

Clara Inspired (1)

Horizon Therapeutics (1)

SLC6A1 Connect (1)

STXBP1 Foundation (1)

University of Pennsylvania Orphan Disease Center (1)

glycerol phenylbutyrate 1100 mg/ml [ravicti] (1)

drug (1)

Other (1)

Interventional (1)

stxbp1 encephalopathy with epilepsy, slc6a1 neurodevelopmental disorder

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Jan 24, 2023